Small Molecules Drive Big Improvements in Immuno-Oncology Therapies

Angewandte Chemie - International Edition

Volumn 57, Issue 16, 2018, Pages 4412-4428

  Huck, Bayard R ^a   Kötzner, Lisa ^a   Urbahns, Klaus ^a  

^a MERCK KGAA   (Germany)

Author keywords

checkpoint inhibitor; combination therapy; kinase inhibitors; small molecules; T cells

Indexed keywords

DISEASES; ONCOLOGY; T-CELLS;

CANCER PATIENTS; CHECKPOINT INHIBITOR; CLINICAL RESPONSE; COMBINATION THERAPY; KINASE INHIBITORS; SMALL MOLECULES;

MOLECULES;

ANTINEOPLASTIC AGENT;

CHEMISTRY; DRUG THERAPY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MOLECULAR LIBRARY; NEOPLASM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; SMALL MOLECULE LIBRARIES;

EID: 85042304571     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201707816     Document Type: Review

References (173)

1. World Health Organization, “Cancer”, Fact Sheet No. 297, updated February 2017, http://www.who.int/mediacentre/factsheets/fs297/en/, (accessed February 21, 2017).
2. F. Balkwill, A. Mantovani, Lancet 2001, 357, 539–545.
3. D. R. Fooksman, S. Vardhana, G. Vasiliver-Shamis, J. Liese, D. Blair, J. Waite, C. Sacristán, G. Victora, A. Zanin-Zhorov, M. L. Dustin, Annu. Rev. Immunol. 2010, 28, 79–105.
4. A. M. Lesokhin, M. K. Callahan, M. A. Postow, J. D. Wolchok, Sci. Transl. Med. 2015, 7, 280sr1.
5. T.-T. Chen, J. Immunother. Cancer 2013, 1, 18.
6. M. Swart, I. Verbrugge, J. B. Beltman, Front. Oncol. 2016, 6, 233;
7. J. Plieth, E. Edhirst, PD-1/PDL1 combination therapies, Vantage, Evaluate Pharma May 2017.
8. G. Suntharalingam, M. R. Perry, S. Ward, S. J. Brett, A. Castello-Cortes, M. D. Brunner, N. Panoskaltsis, N. Engl. J. Med. 2006, 355, 1018–1028.
9. J. L. Adams, J. Smothers, R. Srinivasan, A. Hoos, Nat. Rev. Drug Discovery 2015, 14, 603–622;
10. V. V. Iyer, Anti-Cancer Agents Med. Chem. 2015, 15, 433–452;
11. H. Weinmann, ChemMedChem 2016, 11, 450–466;
12. D. Dhanak, J. P. Edwards, A. Nguyen, P. J. Tummino, Cell Chem. Biol. 2017, 24, 1148–1160.
13. D. Y.-w. Lin, Y. Tanaka, M. Iwasaki, A. G. Gittis, H.-P. Su, B. Mikami, T. Okazaki, T. Honjo, N. Minato, D. N. Garboczi, Proc. Natl. Acad. Sci. USA 2008, 105, 3011–3016.
14. K. M. Zak, R. Kitel, S. Przetocka, P. Golik, K. Guzik, B. Musielak, A. Dömling, G. Dubin, T. A. Holak, Structure 2015, 23, 2341–2348.
15. P. G. N. Sasikumar, M. Ramachandra, S. K. Vadlamani, K. R. Shrimali, K. Subbarao, WO2012/168944 A1, 2012;
16. P. G. N. Sasikumar, M. Ramachandra, WO2013/144704, 2013;
17. P. G. N. Sasikumar, M. Ramachandra, N. S. S. Sudarshan, WO2013/132317, 2013.
18. M. M. Miller, C. Mapelli, M. P. Allen, M. S. Bowsher, M. K. Boy, E. P. Gillis, D. R. Langley, E. Mull, M. A. Poirier, N. Sanghvi, L.-Q. Sun, D. J. Tenney, K.-S. Yeung, J. Zhu, P. C. Reid, P. M. Scola, WO2014/151634, 2014.
19. L. S. Chupak, X. Zheng, WO2015/034820, 2015.
20. K. M. Zak, P. Grudnik, K. Guzik, B. J. Zieba, B. Musielak, A. Dömling, G. Dubin, T. A. Holak, Oncotarget 2016, 7, 30323–30335.
21. P. G. N. Sasikumar, M. Ramachandra, P. G. N. Sasikumar, WO2015/033301, 2015.
22. J. J. Lee, J. D. Powderly, M. R. Patel, J. Brody, E. P. Hamilton, J. R. Infante, G. S. Falchook, H. W. Wang, L. Adams, L. Gong, A. W. Ma, T. Wyant, A. Lazorchak, S. Agarwal, D. P. Tuck, A. Daud, Poster Abstract Number: TPS3099 53rd Annual Meeting Am. Soc. Clin. Oncol. (ASCO), June 2–6, Chicago, 2017.
23. https://clinicaltrials.gov NCT02812875, (accessed July 7, 2017).
24. http://www.curis.com/images/stories/pdfs/posters/Aurigene_EORTC2016CA-327.pdf, (accessed July 7, 2017).
25. L. C. Cantley, Science 2002, 296, 1655–1657.
26. P. Liu, H. Cheng, T. M. Roberts, J. J. Zhao, Nat. Rev. Drug Discovery 2009, 8, 627–644.
27. K. Ali, D. R. Soond, R. Pineiro, T. Hagemann, W. Pearce, E. L. Lim, H. Bouabe, C. L. Scudamore, T. Hancox, H. Maecker, L. Friedman, M. Turner, K. Okkenhaug, B. Vanhaesebroeck, Nature 2014, 510, 407–411.
28. https://clinicaltrials.gov, NCT02332980, (accessed July 28, 2017).
29. S. Joshi, A. R. Singh, M. Zulcic, D. L. Durden, Mol. Cancer Res. 2014, 12, 1520–1531.
30. M. C. Schmid, C. J. Avraamides, H. C. Dippold, I. Franco, P. Foubert, L. G. Ellies, L. M. Acevedo, J. R. E. Manglicmot, X. Song, W. Wrasidlo, S. L. Blair, M. H. Ginsberg, D. A. Cheresh, E. Hirsch, S. J. Field, J. A. Varner, Cancer Cell 2011, 19, 715–727.
31. C. A. Evans, T. Liu, A. Lescarbeau, S. J. Nair, L. Grenier, J. A. Pradeilles, Q. Glenadel, T. Tibbitts, A. M. Rowley, J. P. DiNitto, E. E. Brophy, E. L. O'Hearn, J. A. Ali, D. G. Winkler, S. I. Goldstein, P. O'Hearn, C. M. Martin, J. G. Hoyt, J. R. Soglia, C. Cheung, M. M. Pink, J. L. Proctor, V. J. Palombella, M. R. Tremblay, A. C. Castro, ACS Med. Chem. Lett. 2016, 7, 862–867.
32. M. M. Kaneda, K. S. Messer, N. Ralainirina, H. Li, C. J. Leem, S. Gorjestani, G. Woo, A. V. Nguyen, C. C. Figueiredo, P. Foubert, M. C. Schmid, M. Pink, D. G. Winkler, M. Rausch, V. J. Palombella, J. Kutok, K. McGovern, K. A. Frazer, X. Wu, M. Karin, R. Sasik, E. E. W. Cohen, J. A. Varner, Nature 2016, 539, 437–442.
33. https://clinicaltrials.gov, NCT02637531, (accessed July 28, 2017).
34. L. M. Wakefield, C. S. Hill, Nat. Rev. Cancer 2013, 13, 328–341.
35. R. J. Akhurst, A. Hata, Nat. Rev. Drug Discovery 2012, 11, 790–811.
36. L. Yang, Y. Pang, H. L. Moses, Trends Immunol. 2010, 31, 220–227.
37. https://clinicaltrials.gov, (accessed July 28, 2017)
38. NCT02423343;
39. NCT02734160.
40. R. W. Hendriks, S. Yuvaraj, L. P. Kil, Nat. Rev. Cancer 2014, 14, 219–232.
41. J. A. Dubovsky, K. A. Beckwith, G. Natarajan, J. A. Woyach, S. Jaglowski, Y. Zhong, J. D. Hessler, T.-M. Liu, B. Y. Chang, K. M. Larkin, M. R. Stefanovski, D. L. Chappell, F. W. Frissora, L. L. Smith, K. A. Smucker, J. M. Flynn, J. A. Jones, L. A. Andritsos, K. Maddocks, A. M. Lehman, R. Furman, J. Sharman, A. Mishra, M. A. Caligiuri, A. R. Satoskar, J. J. Buggy, N. Muthusamy, A. J. Johnson, J. C. Byrd, Blood 2013, 122, 2539–2549.
42. I. Sagiv-Barfi, H. E. K. Kohrt, D. K. Czerwinski, P. P. Ng, B. Y. Chang, R. Levy, Proc. Natl. Acad. Sci. USA 2015, 112, E966–E972.
43. https://clinicaltrials.gov, (accessed July 28, 2017)
44. NCT02899078;
45. NCT02940301;
46. NCT02420912;
47. NCT02329847;
48. NCT02733042.
49. https://clinicaltrials.gov, (accessed July 28, 2017)
50. NCT02537444;
51. NCT02362035;
52. NCT02448303;
53. NCT02362048;
54. NCT02454179;
55. NCT02351739.
56. P. Carmeliet, R. K. Jain, Nat. Rev. Drug Discovery 2011, 10, 417–427.
57. I. M. E. Desar, J. F. M. Jacobs, C. A. Hulsbergen-vandeKaa, W. J. G. Oyen, P. F. A. Mulders, W. T. A. van der Graaf, G. J. Adema, C. M. L. van Herpen, I. J. M. de Vries, Int. J. Cancer 2011, 129, 507–512.
58. A. Amin, E. R. Plimack, J. R. Infante, M. S. Ernstoff, B. I. Rini, D. F. McDermott, J. J. Knox, S. K. Pal, M. H. Voss, P. Sharma, C. K. Kollmannsberger, D. Y. C. Heng, J. L. Spratlin, Y. Shen, J. F. Kurland, P. Gagnier, H. J. Hammers, J. Clin. Oncol. 2014, 32, 5010.
59. H. Jiang, S. Hegde, B. L. Knolhoff, Y. Zhu, J. M. Herndon, M. A. Meyer, T. M. Nywening, W. G. Hawkins, I. M. Shapiro, D. T. Weaver, J. A. Pachter, A. Wang-Gillam, D. G. DeNardo, Nat. Med. 2016, 22, 851–860;
60. R. Bueno, R. R. Gill, P. H. Lizotte, Abstract Number: 8555, 53rd Annual Meeting Am. Soc. Clin. Oncol (ASCO), June 2–6 2017 (Chicago);
61. https://clinicaltrials.gov, NCT02758587, (accessed July 28, 2017);
62. https://clinicaltrials.gov, NCT02943317, (accessed July 28, 2017).
63. https://clinicaltrials.gov, NCT02546531, (accessed July 28, 2017).
64. A. M. Menzies, G. V. Long, Clin. Cancer Res. 2014, 20, 2035–2043.
65. L. Liu, P. A. Mayes, S. Eastman, H. Shi, S. Yadavilli, T. Zhang, J. Yang, L. Seestaller-Wehr, S.-Y. Zhang, C. Hopson, L. Tsvetkov, J. Jing, S. Zhang, J. Smothers, A. Hoos, Clin. Cancer Res. 2015, 21, 1639–1651.
66. J. C. Bendell, T. W. Kim, B. C. Goh, J. Wallin, D.-Y. Oh, S.-W. Han, C. B. Lee, M. D. Hellmann, J. Desai, J. H. Lewin, B. J. Solomon, L. Q. M. Chow, W. H. Miller, J. F. Gainor, K. Flaherty, J. R. Infante, M. Das-Thakur, P. Foster, E. Cha, Y.-J. Bang, J. Clin. Oncol. 2016, 34, 3502;
67. https://clinicaltrials.gov, (accessed July 28, 2017), NCT03108131;
68. NCT01656642;
69. NCT02788279.
70. B. Alford, K. Cox, H. Soliman, Drugs Future 2016, 41, 553.
71. J. Casellas, V. Carceller, Drugs Future 2017, 42, 359;
72. Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline with Agreement to Acquire Flexus Biosciences, Inc., Press Release Bristol-Myers Squibb, Feb 23, 2015, (accessed June 8, 2017).
73. https://clinicaltrials.gov, (accessed July 28, 2017)
74. NCT03196232;
75. NCT02752074;
76. NCT02178722;
77. NCT02862457;
78. NCT03085914.
79. C. Jochems, M. Fantini, R. I. Fernando, A. R. Kwilas, R. N. Donahue, L. M. Lepone, I. Grenga, Y.-S. Kim, M. W. Brechbiel, J. L. Gulley, R. A. Madan, C. R. Heery, J. W. Hodge, R. Newton, J. Schlom, K. Y. Tsang, Oncotarget 2016, 7, 37762–37772.
80. Search in: https://clinicaltrials.gov using the search term “Epacadostat”, (accessed July 17, 2017).
81. S. Kumar, J. Waldo, F. Jaipuri, M. Mautino, WO 2014159248, 2014.
82. R. Metz, S. Rust, J. B. DuHadaway, M. R. Mautino, D. H. Munn, N. N. Vahanian, C. J. Link, G. C. Prendergast, Oncoimmunology 2012, 1, 1460–1468.
83. S. Crosignani, M. Kraus, J. Tumang, 24th Int. Symp. Med. Chem. (Aug. 28- Sept. 1) 2016, Abstract 4863;
84. https://clinicaltrials.gov, NCT02764151, (accessed July 28, 2017).
85. S. Ryzhov, S. V. Novitskiy, D. P. Carbone, I. Biaggioni, R. Zaynagetdinov, A. E. Goldstein, M. M. Dikov, I. Feoktistov, Neoplasia 2008, 10, 987–995.
86. D. Preti, P. G. Baraldi, A. R. Moorman, P. A. Borea, K. Varani, Med. Res. Rev. 2015, 35, 790–848.
87. J. A. Ribeiro, A. M. Sebastião, J. Alzheimer′s Dis. 2010, 20, 3–15.
88. R. J. Gillespie, S. J. Bamford, R. Botting, M. Comer, S. Denny, S. Gaur, M. Griffin, A. M. Jordan, A. R. Knight, J. Lerpiniere, S. Leonardi, S. Lightowler, S. McAteer, A. Merrett, A. Misra, A. Padfield, M. Reece, M. Saadi, D. L. Selwood, G. C. Stratton, D. Surry, R. Todd, X. Tong, V. Ruston, R. Upton, S. M. Weiss, J. Med. Chem. 2009, 52, 33–47.
89. https://clinicaltrials.gov, NCT03099161, (accessed July 19, 2017).
90. P. Ho, M.-Y. Hsieh, A. Hotson, R. Miller, I. McCaffery, S. Willingham, Proceedings of the American Association of Cancer Research (AACR), Annual Meeting 2017, Washington, April, 1–5, Abstract No. 5598;
91. https://clinicaltrials.gov, NCT02655822, (accessed March 17, 2017).
92. https://clinicaltrials.gov, NCT02403193, (accessed March 17, 2017).
93. https://clinicaltrials.gov, NCT02740985, (accessed March 17, 2017).
94. A. Borodovsky, Y. Wang, M. YeK. F. Sachsenmeier, H. Deng, K. J. Delsignore, A. J. FretlandR. J. Goodwin, N. Strittmatter, C. Hay, V. R. Sah, D. Lawson, C. Reimer, M. Congreve, J. S. Mason, H. Marshall, P. Lyne, R. Woessner, J. C. Shaw, J. D. Clarke, Proceedings of the American Association of Cancer Research (AACR), Annual Meeting 2017, Washington, April, 1–5, Abstract No. 5580.
95. C. L. Sokol, A. D. Luster, Cold Spring Harbor Perspect. Biol. 2015, 7, a016303;
96. M. T. Chow, A. D. Luster, Cancer Immunology Research 2014, 2, 1125–1131.
97. F. Balkwill, Nat. Rev. Cancer 2004, 4, 540–550;
98. A. Zlotnik, O. Yoshie, Immunity 2012, 36, 705–716.
99. C. W. Steele, S. A. Karim, J. D. G. Leach, P. Bailey, R. Upstill-Goddard, L. Rishi, M. Foth, S. Bryson, K. McDaid, Z. Wilson, C. Eberlein, J. B. Candido, M. Clarke, C. Nixon, J. Connelly, N. Jamieson, C. R. Carter, F. Balkwill, D. K. Chang, T. R. J. Evans, D. Strathdee, A. V. Biankin, R. J. B. Nibbs, S. T. Barry, O. J. Sansom, J. P. Morton, Cancer Cell 2016, 29, 832–845.
100. H. Katoh, D. Wang, T. Daikoku, H. Sun, S. K. Dey, R. N. DuBois, Cancer Cell 2013, 24, 631–644.
101. D. J. Nicholls, K. Wiley, I. Dainty, F. MacIntosh, C. Phillips, A. Gaw, C. K. Mårdh, J. Pharmacol. Exp. Ther. 2015, 353, 340.
102. J. A. Zebala, D. Y. Maeda, A. D. Schuler, 2015, US 20150038461;
103. J. A. Zebala, D. Y. Maeda, A. D. Schuler, 2017, US 20170128474;
104. X. Lu, J. W. Horner, E. Paul, X. Shang, P. Troncoso, P. Deng, S. Jiang, Q. Chang, D. J. Spring, P. Sharma, J. A. Zebala, D. Y. Maeda, Y. A. Wang, R. A. DePinho, Nature 2017, 543, 728–732.
105. https://clinicaltrials.gov, NCT03161431, (accessed July3, 2017).
106. M. Yan, N. Jene, D. Byrne, E. K. A. Millar, S. A. O'Toole, C. M. McNeil, G. J. Bates, A. L. Harris, A. H. Banham, R. L. Sutherland, S. B. Fox, Breast Cancer Res. 2011, 13, R47.
107. B. Debnath, S. Xu, F. Grande, A. Garofalo, N. Neamati, Theranostics 2013, 3, 47–75.
108. L. Reinholdt, M. B. Laursen, A. Schmitz, J. S. Bødker, L. H. Jakobsen, M. Bøgsted, H. E. Johnsen, K. Dybkær, Biomarker Research 2016, 4, 12;
109. https://clinicaltrials.gov NCT00694590, (accessed July 5, 2017).
110. https://clinicaltrials.gov NCT02923531, (accessed July 5, 2017).
111. https://clinicaltrials.gov NCT02823405, (accessed July 5, 2017).
112. S.-B. Peng, X. Zhang, D. Paul, L. M. Kays, W. Gough, J. Stewart, M. T. Uhlik, Q. Chen, Y.-H. Hui, M. J. Zamek-Gliszczynski, J. A. Wijsman, K. M. Credille, L. Z. Yan, Mol. Cancer Ther. 2015, 14, 480–490;
113. https://clinicaltrials.gov NCT02737072, (accessed July 6, 2017).
114. https://clinicaltrials.gov, (accessed July 6, 2017)
115. NCT02907099;
116. NCT02826486.
117. https://clinicaltrials.gov, NCT03154827, (accessed July 6, 2017).
118. C.-B. Xue, A. Wang, Q. Han, Y. Zhang, G. Cao, H. Feng, T. Huang, C. Zheng, M. Xia, K. Zhang, L. Kong, J. Glenn, R. Anand, D. Meloni, D. J. Robinson, L. Shao, L. Storace, M. Li, R. O. Hughes, R. Devraj, P. A. Morton, D. J. Rogier, M. Covington, P. Scherle, S. Diamond, T. Emm, S. Yeleswaram, N. Contel, K. Vaddi, R. Newton, G. Hollis, B. Metcalf, ACS Med. Chem. Lett. 2011, 2, 913–918.
119. T. M. Nywening, A. Wang-Gillam, D. E. Sanford, B. A. Belt, R. Z. Panni, B. M. Cusworth, A. T. Toriola, R. K. Nieman, L. A. Worley, M. Yano, K. J. Fowler, A. C. Lockhart, R. Suresh, B. R. Tan, K.-H. Lim, R. C. Fields, S. M. Strasberg, W. G. Hawkins, D. G. DeNardo, S. P. Goedegebuure, D. C. Linehan, Lancet Oncol. 2016, 17, 651–662.
120. https://clinicaltrials.gov, NCT01413022, (accessed July 5, 2017).
121. https://clinicaltrials.gov, NCT02732938, (accessed July 5, 2017).
122. http://ir.chemocentryx.com/releasedetail.cfm?releaseid=987568, (accessed July 4, 2017);
123. https://clinicaltrials.gov, NCT02345408, (accessed July 5, 2017).
124. http://ir.chemocentryx.com/releasedetail.cfm?releaseid=998139, (accessed July 7, 2017).
125. N. Halama, I. Zoernig, A. Berthel, C. Kahlert, F. Klupp, M. Suarez-Carmona, T. Suetterlin, K. Brand, J. Krauss, F. Lasitschka, T. Lerchl, C. Luckner-Minden, A. Ulrich, M. Koch, J. Weitz, M. Schneider, M. W. Buechler, L. Zitvogel, T. Herrmann, A. Benner, C. Kunz, S. Luecke, C. Springfeld, N. Grabe, C. S. Falk, D. Jaeger, Cancer Cell 2016, 29, 587–601.
126. https://clinicaltrials.gov, NCT01736813, (accessed July 4, 2017).
127. C. H. Percy, R. J. Cherney, V. W. Rosso, J. Li, WO 2011/046916, 2011;
128. P. Norman, Expert Opin. Ther. Pat. 2011, 21, 1919–1924.
129. https://www.clinicaltrials.gov, NCT03184870, (accessed July 3, 2017).
130. M. A. Dawson, T. Kouzarides, Cell 2012, 150, 12–27.
131. H.-J. Kim, S.-C. Bae, Am. J. Transl. Res. 2011, 3, 166–179.
132. M. Terranova-Barberio, S. Thomas, P. N. Munster, Immunotherapy 2016, 8, 705–719.
133. K. Kim, A. D. Skora, Z. Li, Q. Liu, A. J. Tam, R. L. Blosser, L. A. Diaz, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, S. Zhou, Proc. Natl. Acad. Sci. USA 2014, 111, 11774–11779.
134. K. Li, S. Qu, X. Chen, Q. Wu, M. Shi, Int. J. Mol. Sci. 2017, 18, 404.
135. K. Takeda, T. Kaisho, S. Akira, Annu. Rev. Immunol. 2003, 21, 335–376.
136. D. J. Connolly, L. A. J. O'Neill, Curr. Opin. Pharmacol. 2012, 12, 510–518.
137. S. Kaczanowska, A. M. Joseph, E. Davila, J. Leukocyte Biol. 2013, 93, 847–863;
138. S. Adams, Immunotherapy 2009, 1, 949–964;
139. E. J. Hennessy, A. E. Parker, L. A. J. O'Neill, Nat. Rev. Drug Discovery 2010, 9, 293–307.
140. R. J. Mancini, L. Stutts, K. A. Ryu, J. K. Tom, A. P. Esser-Kahn, ACS Chem. Biol. 2014, 9, 1075–1085.
141. J. P. Pradere, D. H. Dapito, R. F. Schwabe, Oncogene 2014, 33, 3485–3495.
142. M. Guha, Nat. Rev. Drug Discovery 2012, 11, 503–505;
143. J. Geisse, I. Caro, J. Lindholm, L. Golitz, P. Stampone, M. Owens, J. Am. Acad. Dermatol. 2004, 50, 722–733;
144. T. Meyer, C. Surber, L. E. French, E. Stockfleth, Expert Opin. Invest. Drugs 2013, 22, 149–159;
145. A. Walter, M. Schäfer, V. Cecconi, C. Matter, M. Urosevic-Maiwald, B. Belloni, N. Schönewolf, R. Dummer, W. Bloch, S. Werner, H.-D. Beer, A. Knuth, M. van den Broek, Nat. Commun. 2013, 4, 1560.
146. N. M. Donin, K. Chamie, A. T. Lenis, A. J. Pantuck, M. Reddy, D. Kivlin, J. Holldack, R. Pozzi, G. Hakim, L. I. Karsh, D. L. Lamm, L. H. Belkoff, A. S. Belldegrun, S. Holden, N. Shore, Urol. Oncol. Semin. Orig. Invest. 2017, 35, 39.e31–39.e37.
147. A. H. Rook, J. M. Gelfand, M. Wysocka, A. B. Troxel, B. Benoit, C. Surber, R. Elenitsas, M. A. Buchanan, D. S. Leahy, R. Watanabe, I. R. Kirsch, E. J. Kim, R. A. Clark, Blood 2015, 126, 1452.
148. A. Z. Dudek, C. Yunis, L. I. Harrison, S. Kumar, R. Hawkinson, S. Cooley, J. P. Vasilakos, K. S. Gorski, J. S. Miller, Clin. Cancer Res. 2007, 13, 7119–7125.
149. D. W. Northfelt, R. K. Ramanathan, P. A. Cohen, D. D. Von Hoff, G. J. Weiss, G. N. Dietsch, K. L. Manjarrez, T. D. Randall, R. M. Hershberg, Clin. Cancer Res. 2014, 20, 3683–3691.
150. https://clinicaltrials.gov NCT02556463, (accessed July 6, 2017).
151. D. H. Dapito, A. Mencin, G.-Y. Gwak, J.-P. Pradere, M.-K. Jang, I. Mederacke, J. M. Caviglia, H. Khiabanian, A. Adeyemi, R. Bataller, J. H. Lefkowitch, M. Bower, R. Friedman, R. B. Sartor, R. Rabadan, R. F. Schwabe, Cancer Cell 2012, 21, 504–516;
152. M. Fukata, A. Chen, A. S. Vamadevan, J. Cohen, K. Breglio, S. Krishnareddy, R. Xu, N. Harpaz, A. J. Dannenberg, K. Subbaramaiah, H. S. Cooper, S. H. Itzkowitz, M. T. Abreu, Gastroenterology 2007, 133, 1869–1881;
153. H. Tye, C. L. Kennedy, M. Najdovska, L. McLeod, W. McCormack, N. Hughes, A. Dev, W. Sievert, C. H. Ooi, T.-o. Ishikawa, H. Oshima, P. S. Bhathal, A. E. Parker, M. Oshima, P. Tan, B. J. Jenkins, Cancer Cell 2012, 22, 466–478;
154. A. Ochi, C. S. Graffeo, C. P. Zambirinis, A. Rehman, M. Hackman, N. Fallon, R. M. Barilla, J. R. Henning, M. Jamal, R. Rao, S. Greco, M. Deutsch, M. V. Medina-Zea, U. B. Saeed, M. O. Ego-Osuala, C. Hajdu, G. Miller, J. Clin. Invest. 2012, 122, 4118–4129;
155. S. Rakoff-Nahoum, R. Medzhitov, Nat. Rev. Cancer 2009, 9, 57–63.
156. M. Fukata, A. Chen, A. Klepper, S. Krishnareddy, A. S. Vamadevan, L. S. Thomas, R. Xu, H. Inoue, M. Arditi, A. J. Dannenberg, M. T. Abreu, Gastroenterology 2006, 131, 862–877;
157. J. Cherfils-Vicini, S. Platonova, M. Gillard, L. Laurans, P. Validire, R. Caliandro, P. Magdeleinat, F. Mami-Chouaib, M.-C. Dieu-Nosjean, W.-H. Fridman, D. Damotte, C. Sautès-Fridman, I. Cremer, J. Clin. Invest. 2010, 120, 1285–1297.
158. Y. Sato, Y. Goto, N. Narita, D. S. B. Hoon, Cancer Microenviron. 2009, 2, 205–214.
159. G. N. Barber, Nat. Rev. Immunol. 2015, 15, 760–770.
160. Q. Wang, X. Liu, Q. Zhou, C. Wang, Expert Opin. Ther. Targets 2015, 19, 1397–1409.
161. J. Fu, D. B. Kanne, M. Leong, L. H. Glickman, S. M. McWhirter, E. Lemmens, K. Mechette, J. J. Leong, P. Lauer, W. Liu, K. E. Sivick, Q. Zeng, K. C. Soares, L. Zheng, D. A. Portnoy, J. J. Woodward, D. M. Pardoll, T. W. Dubensky, Y. Kim, Sci. Transl. Med. 2015, 7, 283ra252.
162. T. W. Dubensky, D. B. Kanne, M. L. Leong, Ther. Adv. Vaccines 2013, 1, 131–143.
163. L. Corrales, L. H. Glickman, S. M. McWhirter, D. B. Kanne, K. E. Sivick, G. E. Katibah, S.-R. Woo, E. Lemmens, T. Banda, J. J. Leong, K. Metchette, T. W. Dubensky, T. F. Gajewski, Cell Rep. 2015, 11, 1018–1030;
164. B. C. Baguley, L.-M. Ching, BioDrugs 1997, 8, 119–127.
165. P. N. Lara, Jr., J.-Y. Douillard, K. Nakagawa, J. von Pawel, M. J. McKeage, I. Albert, G. Losonczy, M. Reck, D.-S. Heo, X. Fan, A. Fandi, G. Scagliotti, J. Clin. Oncol. 2011, 29, 2965–2971.
166. H. Yan, X. Wang, R. KuoLee, W. Chen, Bioorg. Med. Chem. Lett. 2008, 18, 5631–5634.
167. http://www.clinicaltrials.gov NCT02675439, (accessed February 6, 2017);
168. T. R. Vargas, I. Benoit-Lizon, L. Apetoh, Eur. J. Cancer 2017, 75, 86–97;
169. L. Corrales, S. M. McWhirter, T. W. Dubensky, Jr., T. F. Gajewski, J. Clin. Invest. 2016, 126, 2404–2411.
170. https://clinicaltrials.gov NCT03172936, (accessed July 7, 2017).
171. https://clinicaltrials.gov NCT03010176, (accessed July 6, 2017).
172. L. Zitvogel, J. M. Pitt, R. Daillere, M. J. Smyth, G. Kroemer, Nat. Rev. Cancer 2016, 16, 759–773.
173. K. M. Kokolus, M. L. Capitano, C.-T. Lee, J. W.-L. Eng, J. D. Waight, B. L. Hylander, S. Sexton, C.-C. Hong, C. J. Gordon, S. I. Abrams, E. A. Repasky, Proc. Natl. Acad. Sci. USA 2013, 110, 20176–20181.